SAN JOSE, Calif., Feb. 12, 2020 /PRNewswire/ -- RODO Medical announced that it has entered into a non-exclusive, global licensing and distribution agreement with Institut Straumann AG. The original agreement between the two companies provided Straumann with distribution rights in limited jurisdictions, but with this new agreement, Straumann will be able to distribute RODO Medical's proprietary products throughout the world. In addition, the two companies agreed to terminate the option agreement pursuant to which Straumann had a right to increase their ownership in RODO Medical in future years. The termination of the option agreement will enable RODO Medical to raise capital through equity financing and to grow further in the US and other countries.
About RODO Medical
RODO Medical is an innovative dental device company dedicated to improving the quality of life of patients and practitioners since 2009 and is a privately held U.S. company located in San Jose, California. RODO Medical has developed novel devices in implant dentistry, called Smileloc® and Smilekey®, which are cleared by the FDA 510(k) for marketing in the US, and has marketing clearance in Europe (CE Mark).
RODO Medical, Inc., 6399 San Ignacio Ave., Suite 100, San Jose, CA 95119
Tel: +1 408 245 7636
Corporate Communications / Investor Relations
+1 408 245 7636; [email protected]
This release contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied in this release. RODO Medical is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.
SOURCE RODO Medical, Inc.; Straumann